FLUORESCEIN

Generic: FLUORESCEIN

BPI Labs LLCManufacturer
INTRAVENOUSRoute
FLUORESCEIN SODIUMActive Substance
2026-04-30Original Approval

FLUORESCEIN is FDA application ANDA220046, sponsored by BPI LABS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
PRURITUS
60 reports
2
VISUAL ACUITY REDUCED
46 reports
3
NAUSEA
43 reports
4
RASH
37 reports
5
DIZZINESS
36 reports
6
VOMITING
34 reports
7
ANAPHYLACTIC SHOCK
32 reports
8
DYSPNOEA
27 reports
9
URTICARIA
26 reports
10
ANAPHYLACTIC REACTION
23 reports